(MedPage Today) — Though it was not possible to determine causality, a retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/114034Author :
Publish date : 2025-01-31 19:40:55
Copyright for syndicated content belongs to the linked
Source.